EPGNF OTC
Epigenomics AG
1W: +0.0%
1M: +0.0%
3M: +0.0%
YTD: +0.0%
1Y: +0.0%
3Y: +72.3%
5Y: -17.0%
$1.12
+0.00 (+0.00%)
Overview
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Analysis
Technicals
Weather
Peers
ESG
Institutions
Dark Pool
Short Interest
Income Trends
Revenue
$24K
+0.0% ▲
5Y CAGR: -50.9%
Gross Profit
$0
+100.0% ▲
Operating Income
-$389K
+67.0% ▲
Net Income
-$300K
+91.4% ▲
EPS (Diluted)
$-0.34
+91.4% ▲
EBITDA
-$389K
+88.8% ▲
Profit Margins
Year-over-Year Growth
View Full Income Statement
| Line Item | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|
| Revenue | $6M | $485K | $339K | $0 | $24K |
| YoY Growth | +636.7% | -92.2% | -30.1% | -100.0% | +0.0% |
| Cost of Revenue | $136K | $120K | $57K | $12K | $0 |
| Gross Profit | $6M | $365K | $282K | -$12K | $0 |
| Gross Margin | 97.8% | 75.3% | 83.2% | — | 0.0% |
| R&D Expenses | $3M | $6M | $0 | $0 | $0 |
| SG&A Expenses | $4M | $4M | $4M | $1M | $370K |
| Operating Expenses | $8M | $12M | $5M | $1M | $413K |
| Operating Income | -$2M | -$12M | -$4M | -$1M | -$389K |
| Operating Margin | -37.9% | -2484.7% | -1231.2% | — | -1620.9% |
| Interest Expense | $52K | $130K | $0 | $0 | $0 |
| Income Before Tax | -$2M | -$12M | -$4M | -$3M | $0 |
| Tax Expense | $18K | -$77K | $0 | $0 | $0 |
| Net Income | -$2M | -$12M | -$4M | -$3M | -$300K |
| Net Margin | -39.1% | -2479.2% | -1315.8% | — | -1250.1% |
| EPS (Diluted) | $-4.33 | $-14.78 | $-5.23 | $-3.96 | $-0.34 |
| EBITDA | -$2M | -$11M | -$4M | -$3M | -$389K |
| Shares Outstanding | 560370 | 813322 | 853417 | 876949 | 877000 |